Teva sells its only manufacturing plant in Russia
Teva Pharmaceutical's Sales Slump 18% - WSJ
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva pharmaceutical industries News - Latest teva pharmaceutical industries News, Information & Updates - Health News -ET HealthWorld
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical Industries Stock Gives Every Indication Of Being Modestly Undervalued
Teva Pharmaceutical Inds
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
teva News and latest stories | The Jerusalem Post
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month?
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva pharmaceutical industries News - Latest teva pharmaceutical industries News, Information & Updates - Health News -ET HealthWorld
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceutical Industries: Latest News, Photos, Videos on Teva Pharmaceutical Industries - NDTV.COM
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Buy Teva Pharmaceuticals amid positive news, Bernstein says
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
Teva Pharmaceuticals - Wikipedia
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
US accuses Teva of illegally fixing prices of drugs - Taipei Times
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Why Teva Pharmaceutical Industries Stock Is On Fire Today | The Motley Fool
Teva Pharmaceutical Stock Could Double | Barron's
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva, one of the biggest generic makers, joins the the brand-name club
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
